Netrin-1 is a novel regulator of vascular endothelial function in diabetes

• Published in: PloS one 2017-10, Vol.12 (10), p.e0186734
• Main Authors: Toque, Haroldo A, Fernandez-Flores, Aracely, Mohamed, Riyaz, Caldwell, Ruth B, Ramesh, Ganesan, Caldwell, R William
• Format: Article
• Language: English
• Subjects: Angiogenesis; Animals; Anti-inflammatory agents; Aorta; Apoptosis; Axon guidance; Biology; Biology and Life Sciences; Blood Glucose - metabolism; Blood-brain barrier; Cardiovascular system; Care and treatment; Caspase; Caspase-3; Cattle; Cells, Cultured; Complications and side effects; Cyclooxygenase-2; DCC protein; Diabetes; Diabetes mellitus; Diabetes Mellitus, Experimental - pathology; Diabetes Mellitus, Experimental - physiopathology; Diabetic neuropathy; Endothelial cells; Endothelium; Endothelium, Vascular - pathology; Endothelium, Vascular - physiopathology; Genetic aspects; Glycoproteins; Heart attacks; Hypoxia; Inflammation; INK4a protein; Ischemia; Kinases; Laminin; Medicine and Health Sciences; Mice; Mice, Transgenic; mRNA; Nerve Growth Factors - genetics; Nerve Growth Factors - physiology; Netrin-1; NF-κB protein; Nitric oxide; Nitric Oxide - metabolism; Nitric-oxide synthase; Oxidative Stress; Oxidizing agents; p16 Protein; p53 Protein; Pharmacology; Physical Sciences; Physiological aspects; Reactive Oxygen Species - metabolism; Research and Analysis Methods; Rodents; Toxicology; Transgenic mice; Tumor Suppressor Proteins - genetics; Tumor Suppressor Proteins - physiology; Type 2 diabetes
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0186734

Netrin-1, a secreted laminin-like protein identified as an axon guidance molecule, has been shown to be of critical importance in the cardiovascular system. Recent studies have revealed pro-angiogenic, anti-apoptotic and anti-inflammatory properties of netrin-1 as well as cardioprotective actions against myocardial injury in diabetic mice. To examine the role of netrin-1 in diabetes-and high glucose (HG)-induced vascular endothelial dysfunction (VED) using netrin-1 transgenic mice (Tg3) and cultured bovine aortic endothelial cells (BAEC). Overexpression of netrin-1 prevented diabetes-induced VED in aorta from diabetic mice and netrin-1 treatment attenuated HG-induced impairment of nitric oxide synthase (NOS) function in BAECs. Experiments were performed in Tg3 and littermate control (WT) mice rendered diabetic with streptozotocin (STZ) and in BAECs treated with HG (25 mmol/L). Levels of netrin-1 and its receptor DCC, markers of inflammation and apoptosis and vascular function were assessed in aortas from diabetic and non-diabetic Tg3 and WT mice. Vascular netrin-1 in WT mice was reduced under diabetic conditions. Aortas from non-diabetic Tg3 and WT mice showed similar maximum endothelium-dependent relaxation (MEDR) (83% and 87%, respectively). MEDR was markedly impaired in aorta from diabetic WT mice (51%). This effect was significantly blunted in Tg3 diabetic aortas (70%). Improved vascular relaxation in Tg3 diabetic mice was associated with increased levels of phospho-ERK1/2 and reduced levels of oxidant stress, NFκB, COX-2, p16INK4A, cleaved caspase-3 and p16 and p53 mRNA. Netrin-1 treatment prevented the HG-induced decrease in NO production and elevation of oxidative stress and apoptosis in BAECs. Diabetes decreases aortic levels of netrin-1. However, overexpression of netrin-1 attenuates diabetes-induced VED and limits the reduction of NO levels, while increasing expression of p-ERK1/2, and suppressing oxidative stress and inflammatory and apoptotic processes. Enhancement of netrin-1 function may be a useful therapeutic means for preventing vascular dysfunction in diabetes.